Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 5, 1996, Pages 507-510

  Keitel, Wendy A ^a   Cate, Thomas R ^a   Atmar, Robert L ^a   Turner, Connie S ^a   Nino, Diane ^a   Dukes, Cynthia M ^b   Six, Howard R ^b   Couch, Robert B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Connaught Laboratories Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA VACCINE; PLACEBO; VIRUS ANTIBODY;

AGED; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; INFLUENZA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029817016     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.5.507-510.1996     Document Type: Article

References (14)

1. Arden, N. H., P. A. Patriarca, and A. P. Kendal. 1936. Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes, p. 155-168. In Options for the control of influenza. Alan R. Liss, Inc., New York.
2. Centers for Disease Control and Prevention. 1995. Prevention and control of influenza. Morbid. Mortal. Weekly Rep. 44:1-22.
3. Couch, R. B., J. A. Kasel, H. R. Six, T. R. Cate, and J. M. Zahradnik. 1984. Immunological reactions and resistance to infection with influenza virus, p. 119-153. In C. Stuart-Harris and C. Potter (ed.). Molecular virology and epidemiology of influenza. Beecham Symposium. Academic Press, London.
4. Dowdle, W. N., A. P. Kendal, and G. R. Noble. 1979. Influenza viruses, p. 585-609. In E. H. Lenette and N. J. Schmidt (ed.), Diagnostic procedures for viral, rickettsial and chlamydial infections, 5th ed. American Public Health Association, Washington, D.C.
5. Frank, A. L., J. Puck, B. J. Hughes, and T. R. Cale. 1980. Microncutralization test for influenza A and B and parainfluenza 1 and 2 viruses that use continuous cell lines and fresh scrum enhancement. J. Clin. Microbiol. 12: 426-432.
6. Gross, P. A., G. V. Quinnan, M. E. Weksler, P. F. Gaerlan, and C. R. Denning. 1988. Immunization of elderly people with high doses of influenza vaccine. J. Am. Geriatr. Soc. 36:209-212.
7. Keitel, W. A., R. B. Couch, T. R. Cate, K. R. Hess, K. B. Baxter, J. M. Quarles, R. L. Atmar, and H. R. Six. 1994. High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults. J. Clin. Microbiol. 32:2468-2473.
8. Keitel, W. A., R. B. Couch, T. R. Cate, H. R. Six, and B. D. Baxter. 1989. Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB87): attenuation, immunogenicity, and efficacy against homotypic challenge. J. Infect. Dis. 161: 22-26.
9. Mostow, S. R., S. C. Schoenbaum, W. R. Dowdle, M. T. Coleman, H. S. Kaye, and J. C. Hierholzer. 1970. Studies on inactivated influenza vaccines. Am. J. Epidemiol. 92:248-256.
10. Palache, A. M., W. E. P. Beyer, M. J. W. Sprenger, N. Masurel, S. de Jonge, A. Vardy, B. Charpentier, J. Noury, W. C. A. van Beek, R. J. A. Borst, G. J. Ligthart, G. Keren, and E. Rubinstein. 1993. Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers. Vaccine 11:3-93.
11. Powers, D. C., S. D. Sears, B. R. Murphy, B. Thumar, and M. L. Clements. 1989. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines. J. Clin. Microbiol. 27:2666-2671.
12. Powers, D. C., G. E. Smith, E. L. Anderson, D. J. Kennedy, C. S. Hackett, B. E. Wilkinson, F. Volvovitz, R. B. Belshe, and J. J. Trcanor. 1995. Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults. J. Infect. Dis. 171:1595-1599.
13. Ruben, F. L., and G. G. Jackson. 1972. A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity. J. Infect.-Dis. 125:656-664.
14. Treanor, J. J., R. F. Betts, G. E. Smith, B. E. Wilkinson, C. S. Hackett, E. L. Anderson, R. B. Belshe, and D. C. Powers. 1995. Evaluation of a recombinant hemagglutinin as an influenza vaccine in young and elderly adults, abstr. 416, p. 120. In Program and abstracts of the 33rd Annual Meeting of the Infectious Disease Society of America. Infectious Disease Society of America, Washington, D.C.